Insights into the mode of action of the two-peptide lantibiotic haloduracin.

PubWeight™: 1.32‹?› | Rank: Top 10%

🔗 View Article (PMC 2812937)

Published in ACS Chem Biol on October 16, 2009

Authors

Trent J Oman1, Wilfred A van der Donk

Author Affiliations

1: Department of Chemistry, University of Illinois at Urbana-Champaign and the Howard Hughes Medical Institute, Urbana, Illinois 61801, USA.

Articles citing this

Production of lantipeptides in Escherichia coli. J Am Chem Soc (2010) 1.56

Plantazolicin, a novel microcin B17/streptolysin S-like natural product from Bacillus amyloliquefaciens FZB42. J Bacteriol (2010) 1.47

Structural Characterization and Bioactivity Analysis of the Two-Component Lantibiotic Flv System from a Ruminant Bacterium. Cell Chem Biol (2016) 1.45

The sequence of the enterococcal cytolysin imparts unusual lanthionine stereochemistry. Nat Chem Biol (2013) 1.09

Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin. ACS Chem Biol (2011) 1.06

A general method for fluorescent labeling of the N-termini of lanthipeptides and its application to visualize their cellular localization. J Am Chem Soc (2013) 0.95

Cerecidins, novel lantibiotics from Bacillus cereus with potent antimicrobial activity. Appl Environ Microbiol (2014) 0.95

Haloduracin α binds the peptidoglycan precursor lipid II with 2:1 stoichiometry. J Am Chem Soc (2011) 0.94

Non-proteinogenic amino acids in lacticin 481 analogues result in more potent inhibition of peptidoglycan transglycosylation. ACS Chem Biol (2012) 0.86

Thusin, a Novel Two-Component Lantibiotic with Potent Antimicrobial Activity against Several Gram-Positive Pathogens. Front Microbiol (2016) 0.85

Chemical synthesis and biological activity of analogues of the lantibiotic epilancin 15X. J Am Chem Soc (2012) 0.84

Easy and rapid purification of highly active nisin. Int J Pept (2011) 0.84

Investigating the importance of charged residues in lantibiotics. Bioeng Bugs (2011) 0.82

Michael-type cyclizations in lantibiotic biosynthesis are reversible. ACS Chem Biol (2015) 0.81

High-resolution crystal structure reveals molecular details of target recognition by bacitracin. Proc Natl Acad Sci U S A (2013) 0.80

Discovery and Characterization of Bicereucin, an Unusual d-Amino Acid-Containing Mixed Two-Component Lantibiotic. J Am Chem Soc (2016) 0.80

Mode of action and structure-activity relationship studies of geobacillin I. J Antibiot (Tokyo) (2013) 0.79

Fermentation stage-dependent adaptations of Bacillus licheniformis during enzyme production. Microb Cell Fact (2013) 0.78

A gene network engineering platform for lactic acid bacteria. Nucleic Acids Res (2015) 0.78

Lichenicidin biosynthesis in Escherichia coli: licFGEHI immunity genes are not essential for lantibiotic production or self-protection. Appl Environ Microbiol (2011) 0.78

The high resolution structure of tyrocidine A reveals an amphipathic dimer. Biochim Biophys Acta (2014) 0.78

Efficacy of Lantibiotic Treatment of Staphylococcus aureus-Induced Skin Infections, Monitored by In Vivo Bioluminescent Imaging. Antimicrob Agents Chemother (2016) 0.76

Towards Biocontained Cell Factories: An Evolutionarily Adapted Escherichia coli Strain Produces a New-to-nature Bioactive Lantibiotic Containing Thienopyrrole-Alanine. Sci Rep (2016) 0.76

Synergistic effect of haloduracin and chloramphenicol against clinically important Gram-positive bacteria. Biotechnol Rep (Amst) (2016) 0.75

Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes. Chem Rev (2017) 0.75

Articles cited by this

Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science (1999) 5.30

Biosynthesis and mode of action of lantibiotics. Chem Rev (2005) 4.59

Construction of a Bacillus subtilis double mutant deficient in extracellular alkaline and neutral proteases. J Bacteriol (1984) 4.15

Lantibiotics: peptides of diverse structure and function. Annu Rev Microbiol (2007) 4.00

Lipid II as a target for antibiotics. Nat Rev Drug Discov (2006) 3.01

Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol Microbiol (1998) 2.69

The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol Microbiol (2006) 2.53

Bacterial lantibiotics: strategies to improve therapeutic potential. Curr Protein Pept Sci (2005) 2.21

Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic. Proc Natl Acad Sci U S A (2006) 2.19

The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob Agents Chemother (1998) 2.06

Structure-activity relationship studies of the two-component lantibiotic haloduracin. Chem Biol (2008) 1.95

Multiparameter flow cytometric analysis of antibiotic effects on membrane potential, membrane permeability, and bacterial counts of Staphylococcus aureus and Micrococcus luteus. Antimicrob Agents Chemother (2000) 1.75

Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity. Biochemistry (2004) 1.61

Mersacidin, a new antibiotic from Bacillus. Fermentation, isolation, purification and chemical characterization. J Antibiot (Tokyo) (1992) 1.58

Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase. Chem Biol (2006) 1.56

Protein engineering of lantibiotics. Antonie Van Leeuwenhoek (1996) 1.54

Promising antibiotic candidate identified. Science (1999) 1.46

The importance of the leader sequence for directing lanthionine formation in lacticin 481. Biochemistry (2008) 1.46

Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering. Appl Environ Microbiol (1995) 1.45

Plantaricin W from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics. Microbiology (2001) 1.34

Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations. Antimicrob Agents Chemother (2005) 1.30

Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147. J Biol Chem (1999) 1.29

Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol (1998) 1.29

Lacticin 3147 displays activity in buffer against gram-positive bacterial pathogens which appear insensitive in standard plate assays. Lett Appl Microbiol (1999) 1.21

Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125. FEMS Microbiol Lett (2007) 1.21

Construction of an expression system for site-directed mutagenesis of the lantibiotic mersacidin. Appl Environ Microbiol (2003) 1.20

Isolation and characterization of genetically engineered gallidermin and epidermin analogs. Appl Environ Microbiol (1995) 1.19

Conversion of Bacillus subtilis 168 to a subtilin producer by competence transformation. J Bacteriol (1991) 1.19

Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5. Appl Environ Microbiol (1996) 1.18

Solution structures of nisin A and its two major degradation products determined by n.m.r. Biochem J (1992) 1.16

Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model. J Antimicrob Chemother (1998) 1.15

Structure-activity study of the lantibiotic mutacin II from Streptococcus mutans T8 by a gene replacement strategy. Appl Environ Microbiol (1998) 1.10

Each peptide of the two-component lantibiotic lacticin 3147 requires a separate modification enzyme for activity. Microbiology (2000) 1.08

Inhibition of Bacillus anthracis spore outgrowth by nisin. Antimicrob Agents Chemother (2008) 1.08

Structure-activity relationships in the peptide antibiotic nisin: role of dehydroalanine 5. Appl Environ Microbiol (1996) 1.04

Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis. FEBS Lett (2005) 1.03

The tetracyclic lantibiotic actagardine. 1H-NMR and 13C-NMR assignments and revised primary structure. Eur J Biochem (1995) 1.03

Effect of subtilin and nisin on the spores of Bacillus coagulans. J Bacteriol (1959) 1.02

Nisin Resistance in Clostridium botulinum Spores and Vegetative Cells. Appl Environ Microbiol (1997) 1.01

Structure and biological activity of chemically modified nisin A species. Eur J Biochem (1996) 1.00

Substrate analogues to study cell-wall biosynthesis and its inhibition. Curr Opin Chem Biol (2002) 0.97

Engineering a disulfide bond and free thiols in the lantibiotic nisin Z. Eur J Biochem (2000) 0.95

A lesson in efficient killing from two-component lantibiotics. Mol Microbiol (2006) 0.95

Articles by these authors

(truncated to the top 100)

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38

Biosynthesis and mode of action of lantibiotics. Chem Rev (2005) 4.59

Lantibiotics: peptides of diverse structure and function. Annu Rev Microbiol (2007) 4.00

Structure and mechanism of the lantibiotic cyclase involved in nisin biosynthesis. Science (2006) 3.29

Follow the leader: the use of leader peptides to guide natural product biosynthesis. Nat Chem Biol (2010) 3.16

Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity. Science (2004) 2.83

Biosynthesis of phosphonic and phosphinic acid natural products. Annu Rev Biochem (2009) 2.19

Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic. Proc Natl Acad Sci U S A (2006) 2.19

Catalytic promiscuity in the biosynthesis of cyclic peptide secondary metabolites in planktonic marine cyanobacteria. Proc Natl Acad Sci U S A (2010) 2.18

Discovery, biosynthesis, and engineering of lantipeptides. Annu Rev Biochem (2012) 2.01

Structure-activity relationship studies of the two-component lantibiotic haloduracin. Chem Biol (2008) 1.95

Lacticin 481 synthetase phosphorylates its substrate during lantibiotic production. J Am Chem Soc (2005) 1.76

Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights. PLoS Biol (2010) 1.74

Unusual transformations in the biosynthesis of the antibiotic phosphinothricin tripeptide. Nat Chem Biol (2007) 1.72

Genome mining for ribosomally synthesized natural products. Curr Opin Chem Biol (2010) 1.58

Production of lantipeptides in Escherichia coli. J Am Chem Soc (2010) 1.56

Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase. Chem Biol (2006) 1.56

Synthesis of methylphosphonic acid by marine microbes: a source for methane in the aerobic ocean. Science (2012) 1.53

Lantibiotics from Geobacillus thermodenitrificans. Proc Natl Acad Sci U S A (2012) 1.53

New insight into the mechanism of methyl transfer during the biosynthesis of fosfomycin. Chem Commun (Camb) (2006) 1.53

An unusual carbon-carbon bond cleavage reaction during phosphinothricin biosynthesis. Nature (2009) 1.51

Heterologous production of fosfomycin and identification of the minimal biosynthetic gene cluster. Chem Biol (2006) 1.47

The importance of the leader sequence for directing lanthionine formation in lacticin 481. Biochemistry (2008) 1.46

Sublancin is not a lantibiotic but an S-linked glycopeptide. Nat Chem Biol (2011) 1.44

Evolution of lanthipeptide synthetases. Proc Natl Acad Sci U S A (2012) 1.44

In vitro mutasynthesis of lantibiotic analogues containing nonproteinogenic amino acids. J Am Chem Soc (2009) 1.37

Mechanistic investigations of the dehydration reaction of lacticin 481 synthetase using site-directed mutagenesis. Biochemistry (2007) 1.36

Radical-mediated enzymatic methylation: a tale of two SAMS. Acc Chem Res (2011) 1.33

The leader peptide is not required for post-translational modification by lacticin 481 synthetase. J Am Chem Soc (2007) 1.31

Biosynthesis of rhizocticins, antifungal phosphonate oligopeptides produced by Bacillus subtilis ATCC6633. Chem Biol (2010) 1.30

Identification of essential catalytic residues of the cyclase NisC involved in the biosynthesis of nisin. J Biol Chem (2007) 1.25

Post-translational modifications during lantibiotic biosynthesis. Curr Opin Chem Biol (2004) 1.24

Biomimetic stereoselective formation of methyllanthionine. Org Lett (2002) 1.23

SpaC and NisC, the cyclases involved in subtilin and nisin biosynthesis, are zinc proteins. Biochemistry (2003) 1.23

Mutants of the zinc ligands of lacticin 481 synthetase retain dehydration activity but have impaired cyclization activity. Biochemistry (2007) 1.22

Hydroperoxylation by hydroxyethylphosphonate dioxygenase. J Am Chem Soc (2009) 1.22

Characterization and structure of DhpI, a phosphonate O-methyltransferase involved in dehydrophos biosynthesis. Proc Natl Acad Sci U S A (2010) 1.20

Structural characterization of four prochlorosins: a novel class of lantipeptides produced by planktonic marine cyanobacteria. Biochemistry (2012) 1.18

Molecular cloning and heterologous expression of the dehydrophos biosynthetic gene cluster. Chem Biol (2010) 1.17

Biosynthesis of 2-hydroxyethylphosphonate, an unexpected intermediate common to multiple phosphonate biosynthetic pathways. J Biol Chem (2008) 1.17

In vitro reconstitution and substrate specificity of a lantibiotic protease. Biochemistry (2008) 1.16

Distributive and directional behavior of lantibiotic synthetases revealed by high-resolution tandem mass spectrometry. J Am Chem Soc (2009) 1.16

On the substrate specificity of dehydration by lacticin 481 synthetase. J Am Chem Soc (2007) 1.16

Biomimetic studies on the mechanism of stereoselective lanthionine formation. Org Biomol Chem (2003) 1.15

Nine post-translational modifications during the biosynthesis of cinnamycin. J Am Chem Soc (2011) 1.15

Ribosomally synthesized and post-translationally modified peptide natural products: new insights into the role of leader and core peptides during biosynthesis. Chemistry (2013) 1.15

Chapter 21. In vitro studies of lantibiotic biosynthesis. Methods Enzymol (2009) 1.13

Relaxing the nicotinamide cofactor specificity of phosphite dehydrogenase by rational design. Biochemistry (2003) 1.13

In vitro activity of the nisin dehydratase NisB. Proc Natl Acad Sci U S A (2013) 1.10

Biosynthesis of the antimicrobial peptide epilancin 15X and its N-terminal lactate. Chem Biol (2011) 1.10

Synthesis of isotopically labeled arachidonic acids to probe the reaction mechanism of prostaglandin H synthase. J Am Chem Soc (2002) 1.09

The sequence of the enterococcal cytolysin imparts unusual lanthionine stereochemistry. Nat Chem Biol (2013) 1.09

An engineered lantibiotic synthetase that does not require a leader peptide on its substrate. J Am Chem Soc (2012) 1.09

The selenocysteine-substituted blue copper center: spectroscopic investigations of Cys112SeCys Pseudomonas aeruginosa azurin. J Am Chem Soc (2004) 1.09

The dehydratase activity of lacticin 481 synthetase is highly processive. J Am Chem Soc (2006) 1.08

Inhibition of Bacillus anthracis spore outgrowth by nisin. Antimicrob Agents Chemother (2008) 1.08

Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin. ACS Chem Biol (2011) 1.06

Regeneration of cofactors for use in biocatalysis. Curr Opin Biotechnol (2003) 1.04

Synthesis of site-specifically labeled arachidonic acids as mechanistic probes for prostaglandin H synthase. Org Lett (2004) 1.04

Heterologous expression and purification of SpaB involved in subtilin biosynthesis. Biochem Biophys Res Commun (2002) 1.03

Investigation of the substrate specificity of lacticin 481 synthetase by using nonproteinogenic amino acids. Chembiochem (2009) 1.02

Phosphite dehydrogenase: a versatile cofactor-regeneration enzyme. Angew Chem Int Ed Engl (2002) 1.02

Heterologous expression, purification, and characterization of a highly active xylose reductase from Neurospora crassa. Appl Environ Microbiol (2005) 1.02

Reassignment of the structure of the antibiotic A53868 reveals an unusual amino dehydrophosphonic acid. Angew Chem Int Ed Engl (2007) 1.02

On the stereochemistry of 2-hydroxyethylphosphonate dioxygenase. J Am Chem Soc (2011) 1.00

Enzymatic hydrogen atom abstraction from polyunsaturated fatty acids. Chem Commun (Camb) (2003) 0.98

Different biosynthetic pathways to fosfomycin in Pseudomonas syringae and Streptomyces species. Antimicrob Agents Chemother (2012) 0.98

On the regioselectivity of thioether formation by lacticin 481 synthetase. Org Lett (2007) 0.98

Use of lantibiotic synthetases for the preparation of bioactive constrained peptides. Bioorg Med Chem Lett (2008) 0.98

Biosynthesis of the class III lantipeptide catenulipeptin. ACS Chem Biol (2012) 0.97

A price to pay for relaxed substrate specificity: a comparative kinetic analysis of the class II lanthipeptide synthetases ProcM and HalM2. J Am Chem Soc (2014) 0.96

Comparison of the properties of prostaglandin H synthase-1 and -2. Prog Lipid Res (2003) 0.96

Structural and mechanistic insights into C-P bond hydrolysis by phosphonoacetate hydrolase. Chem Biol (2011) 0.95

A general method for fluorescent labeling of the N-termini of lanthipeptides and its application to visualize their cellular localization. J Am Chem Soc (2013) 0.95

Site-directed mutagenesis of active site residues of phosphite dehydrogenase. Biochemistry (2005) 0.94

Isotope sensitive branching and kinetic isotope effects in the reaction of deuterated arachidonic acids with human 12- and 15-lipoxygenases. Biochemistry (2008) 0.94

Haloduracin α binds the peptidoglycan precursor lipid II with 2:1 stoichiometry. J Am Chem Soc (2011) 0.94

Synthesis and activity of thioether-containing analogues of the complement inhibitor compstatin. ACS Chem Biol (2011) 0.94

Mechanistic studies of Ser/Thr dehydration catalyzed by a member of the LanL lanthionine synthetase family. Biochemistry (2011) 0.94

Revisiting the biosynthesis of dehydrophos reveals a tRNA-dependent pathway. Proc Natl Acad Sci U S A (2013) 0.93

Insights into the evolution of lanthipeptide biosynthesis. Protein Sci (2013) 0.93

Kinetic and structural investigations of the allosteric site in human epithelial 15-lipoxygenase-2. Biochemistry (2009) 0.93

Structural characterization of arachidonyl radicals formed by aspirin-treated prostaglandin H synthase-2. J Biol Chem (2002) 0.93

Model studies of the histidine-tyrosine cross-link in cytochrome C oxidase reveal the flexible substituent effect of the imidazole moiety. Org Lett (2005) 0.92

Phosphonate biosynthesis and catabolism: a treasure trove of unusual enzymology. Curr Opin Chem Biol (2013) 0.92

Use of a phosphonate methyltransferase in the identification of the fosfazinomycin biosynthetic gene cluster. Angew Chem Int Ed Engl (2013) 0.92

Structure and mechanism of enzymes involved in biosynthesis and breakdown of the phosphonates fosfomycin, dehydrophos, and phosphinothricin. Arch Biochem Biophys (2010) 0.92

Mechanistic studies on the substrate-tolerant lanthipeptide synthetase ProcM. J Am Chem Soc (2014) 0.92

Genetic and biochemical characterization of a pathway for the degradation of 2-aminoethylphosphonate in Sinorhizobium meliloti 1021. J Biol Chem (2011) 0.91

Transforming a blue copper into a red copper protein: engineering cysteine and homocysteine into the axial position of azurin using site-directed mutagenesis and expressed protein ligation. J Am Chem Soc (2010) 0.91

Lacticin 481 synthetase as a general serine/threonine kinase. ACS Chem Biol (2009) 0.91

Aziridine-2-carboxylic acid-containing peptides: application to solution- and solid-phase convergent site-selective peptide modification. J Am Chem Soc (2005) 0.91

Catalytic promiscuity of a bacterial α-N-methyltransferase. FEBS Lett (2012) 0.90

High divergence of the precursor peptides in combinatorial lanthipeptide biosynthesis. ACS Chem Biol (2014) 0.90

Site-selective conjugation of thiols with aziridine-2-carboxylic acid-containing peptides. J Am Chem Soc (2004) 0.90

New developments in lantibiotic biosynthesis and mode of action. Curr Opin Microbiol (2005) 0.90

Structure-activity relationships of the phosphonate antibiotic dehydrophos. Chem Commun (Camb) (2010) 0.89

Properties and reactivity of chlorovinylcobalamin and vinylcobalamin and their implications for vitamin B12-catalyzed reductive dechlorination of chlorinated alkenes. J Am Chem Soc (2005) 0.88

Heterologous production of the lantibiotic Ala(0)actagardine in Escherichia coli. Chem Commun (Camb) (2012) 0.88

In vitro characterization of a heterologously expressed nonribosomal Peptide synthetase involved in phosphinothricin tripeptide biosynthesis. Biochemistry (2009) 0.88